Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Kent jail describes MOUD efforts; staff report limited reach amid short stays and diversion challenges
Summary
The Kent Correctional Facility described its medication‑for‑opioid‑use disorder (MOUD/MAT) program, procedural safeguards, participation and diversion statistics, and reentry referrals; staff said short average stays and regulatory costs limit program scale.
Commander Armstrong briefed the council workshop on April 15 about the jail’s medication‑assisted treatment (MAT) / medication for opioid use disorder (MOUD) program.
Armstrong said the jail’s program focuses primarily on MOUD medications such as buprenorphine formulations (Subutex/Suboxone variations) and naloxone distribution at release. He explained that methadone is difficult to provide on site because of program regulations and logistics; long‑acting injectable formulations exist but are cost‑prohibitive for routine use in the facility.
The jail resumed a MOUD dosing program in November 2023, with its medical provider prescribing Subutex in the facility and…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
